<DOC>
	<DOC>NCT01796535</DOC>
	<brief_summary>This is a multi-center, non-randomized post marketing surveillance registry including up to 125 patients treated with the PerX360º System™. Patients will receive a follow-up evaluation at the per physician defined time points: at discharge, an Interim 1 visit (1 month), an Interim 2 visit (3-6 months) and a Final visit (12 months). Imaging obtained at visits should be per standard of care.</brief_summary>
	<brief_title>The PerX360º System™ Registry</brief_title>
	<detailed_description>For all patients participating in the registry, the following outcomes will be analyzed: - Change in pain score on the Visual Analog Scale(VAS) from baseline for leg pain - Change in pain score on the Visual Analog Scale(VAS) from baseline for back pain - Change in Oswestry Disability Index (ODI) score from baseline - Proportion of patients with a device related complication - Proportion of patients with lack of revision, removal, or reoperation - Proportion of patients with radiographic fusion</detailed_description>
	<criteria>Patient understands the nature of the procedure and provides written informed consent Patient is willing to return to the treating physician for his/her routine followup visits up to 12 months post treatment Age &gt; 18 years Patient is treated with the Optiport™ and Opticage™ products None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>